37 mg/L 3 hours after the dose
In uncomplicated urinary tract infections, skin and skin structure infections, disseminated gonococcal infections, and uncomplicated pneumonia, a 750 mg dose every 8 hours is recommended
Solutions of Cefuroxime for Injection, USP range in color from light yellow to amber, depending on the concentration and diluent used
Cefuroxime for Injection, USP in the dry state should be stored at 20-25° (68-77°F) [see USP Controlled Room Temperature] and protected from light
Discuss the risks and However, during infusion of the solution containing Cefuroxime, it is advisable to temporarily discontinue administration of any other solutions at the same site
In studies in pregnant mice and rats administered oral cefuroxime axetil during organogenesis at 14 and 9 times the maximum recommended human dose Fertility studies in rats (males dosed for 70 days prior to and through mating; females dosed 21 days prior to mating through lactation) at doses up to 1,000 mg/kg/day (9 times the
Pediatric Use The safety and effectiveness of cefuroxime axetil have been established for pediatric patients aged 3 months to 12 years for acute bacterial
4 mEq) of sodium per gram of cefuroxime activity
Because cefuroxime is excreted in human milk, consideration should be given to discontinuing nursing temporarily during treatment with cefuroxime axetil
Cefuroxime comes as a tablet and a suspension (liquid) to take by mouth
Following the IM administration of a 750-mg single dose, urinary concentrations averaged 1,300 mcg/mL during the first 8 hours
consideration should be given to discontinuing nursing temporarily during treatment with cefuroxime axetil Cefuroxime is one of the antibiotics that taken during pregnancy can be without harming the child or the mother
However, there is no clinical data on the use of cefuroxime axetil during pregnancy
[4] One mother received cefuroxime axetil 500 mg orally three times daily for acute mastitis of the left breast following incision and drainage of the lesion